From: Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Complication | Total vivax | Total patients with severity sign | Pooled prevalence, % | 95% CI, % |
---|---|---|---|---|
Death | 46411 | 353 | 0.3 | 0.1–0.4 |
Cerebral malaria | 45845 | 532 | 0.8 | 0.5–1.1 |
Multiple convulsions | 46386 | 88 | 0.2 | 0–0.5 |
Renal dysfunction | 46341 | 244 | 1.1 | 0.3–1.9 |
Respiratory dysfunction | 46411 | 144 | 0.3 | 0.1–0.5 |
Hepatic dysfunction | 46536 | 727 | 4.2 | 3.2–5.2 |
Abnormal bleeding/DIC | 46346 | 206 | 0.6 | 0.2–1 |
Haemoglobinuria | 46411 | 93 | 0.1 | 0–0.4 |
Hypoglycaemia | 46381 | 44 | 1.8 | 0.9–2.7 |
Metabolic acidosis | 46341 | 138 | 1 | 0–2.3 |
Circulatory collapse/Shock | 46411 | 67 | 5.1 | 2.5–7.7 |
Severe anaemia | 46411 | 2276 | 4 | 2.9–5.1 |
Severe thrombocytopenia | 45775 | 888 | 8.6 | 5.4–11.8 |